STC2 and hepatocellular carcinoma: Recently, several clinicopathological studies have identified serum STC2 levels are elevated in patients with HCC, gastric cancer and colorectal cancer, and particularly high serum STC2 levels are associated with poor prognosis [20, 50–52], indicating secreted STC2 could perform its biological functions through an endocrine mechanism at organism levels.